Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin acetate after conservative surgery for prevention of adenomyoma recurrence
ChiCTR1800014340Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Jan 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of triptorelin in Adenomyoma (2 arms), sponsored by Tongji Hospital. Primary endpoints: Size of uterus and Size of adenomyoma. Started Jan 2018; status: recruiting.
02
Drugs
triptorelin
03
Conditions
Adenomyoma
Beyond the preview
Go deeper on ChiCTR1800014340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014340.